Menu Search
Equities

Ypsomed Holding AG

YPSN:SWX

Ypsomed Holding AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)354.50
  • Today's Change6.50 / 1.87%
  • Shares traded5.69k
  • 1 Year change+22.03%
  • Beta1.3653
Data delayed at least 15 minutes, as of Nov 22 2024 10:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform3
Hold2
Sell1
Strong Sell0

Share price forecast in CHF

The 5 analysts offering 12 month price targets for Ypsomed Holding AG have a median target of 430.00, with a high estimate of 495.00 and a low estimate of 326.00. The median estimate represents a 23.56% increase from the last price of 348.00.
High42.2%495.00
Med23.6%430.00
Low-6.3%326.00

Dividends in CHF

In 2024, Ypsomed Holding AG reported a dividend of 2.00 CHF, which represents a 53.85% increase over last year. The 5 analysts covering the company expect dividends of 3.33 CHF for the upcoming fiscal year, an increase of 66.70%.
Div growth (TTM)53.85%
More ▼

Earnings history & estimates in CHF

Ypsomed Holding AG reported annual 2024 earnings of 5.74 per share on May 22, 2024.
Average growth rate+101.85%
More ▼

Revenue history & estimates in CHF

Ypsomed Holding AG had revenues for the full year 2024 of 548.46m. This was 10.25% above the prior year's results.
Average growth rate+8.73%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.